Author:
Soulen Michael C.,Rilling William S.
Publisher
Society of Nuclear Medicine
Reference10 articles.
1. The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres;Westcott;Adv Radiat Oncol.,2016
2. Silvestrini E . FDA 510(k) clearance process. Drugwatch website. https://www.drugwatch.com/fda/510k-clearance/. Modified September 5, 2023. Accessed December 21, 2023.
3. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials;Wasan;Lancet Oncol.,2017
4. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
5. Effect of yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: a systematic review and meta-analysis;Lemieux;PLoS One.,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献